It is a chemicals private limited company based in Dehradun, Uttarakhand, India, established in 2020.
2020 | Dehradun, Uttarakhand, India | ActiveSupriti Pharmaceuticals Private Limited, a active private limited company, was established on 14 December 2020 in Dehradun, Uttarakhand, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239UR2020PTC011868. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Nishad Arora (Director), Amit Suri (Director), Preetika Suri (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 15, Preet Vihar, Dehradun, Uttarakhand, 248001.
U24239UR2020PTC011868
011868
14 December 2020
₹0.10 M
₹0.10 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Supriti Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishad Arora | Director | 05 Jan 2021 | Current |
| Amit Suri | Director | 05 Jan 2021 | Current |
| Preetika Suri | Director | 14 Dec 2020 | Current |
| Sunita Jolly | Director | 14 Dec 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Supriti Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1249.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 149.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Supriti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Supriti Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Supriti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriti Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Supriti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Supriti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was completed.
The activity Nishad Arora was appointed as a Director was appointed as a Director on 05 Jan 2021 & has been associated with this company since 4 years 10 months . was completed.
Amit Suri was appointed as a Director was appointed as a Director on 05 Jan 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The activity Preetika Suri was appointed as a Director was appointed as a Director on 14 Dec 2020 & has been associated with this company since 4 years 11 months . was completed.
Progress on Sunita Jolly was appointed as a Director was appointed as a Director on 14 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Supriti Pharmaceuticals Private Limited is U24239UR2020PTC011868.
Supriti Pharmaceuticals Private Limited is headquartered at 15, Preet Vihar, Dehradun, Uttarakhand, 248001.
Supriti Pharmaceuticals Private Limited was incorporated on 14 December 2020.
The current directors of Supriti Pharmaceuticals Private Limited are
The primary industry of Supriti Pharmaceuticals Private Limited is Chemicals.
Supriti Pharmaceuticals Private Limited is unlisted.
The authorized capital of Supriti Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX